IFN alpha Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk
Cancer discovery（2022）
摘要
In this issue, Hu and colleagues unveil that IFN alpha administration combined with anti-PD-1 therapy can potentiate murine and human CD8(+) T-cell antitumor response in hepatocellular carcinoma, highlighting a novel therapeutic strategy for hepatocellular carcinoma.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要